[Modern strategies for the treatment of childhood obesity].
Probl Endokrinol (Mosk) · 2022
Last updated 2026-05-28In Russia, childhood obesity is rising, and treatment often combines diet, exercise, therapy, and support. Medication like Liraglutide, which reduces appetite, is being considered as part of this approach because studies show it is effective and has few side effects in adolescents.
AI summary of the abstract below.
| Journal | Probl Endokrinol (Mosk), 2022 |
|---|---|
| Citations | 2 |
| Relative citation ratio | 0.19 |
| NIH percentile | 12 |
| Molecules | — |
| Conditions studied | Obesity |
Abstract
The prevalence of obesity and related metabolic disorders in children and adolescents in the Russian Federation is steadily increasing, which requires healthcare professionals to search for new methods of treatment and prevention. The treatment of childhood obesity should be based on a comprehensive approach, including diet therapy, increased physical activity, behavioral therapy and psychological support. To increase the effectiveness of the formation of new eating habits and proper eating behavior, as well as to increase the adherence of children and adolescents to treatment, drug therapy of obesity is used, aimed primarily at reducing appetite. Considering the efficacy and safety of glucagon-like peptide 1 analog (Liraglutide) in adolescents, as well as a small number of gastrointestinal side effects, this drug is promising in the complex treatment of childhood obesity. This review presents an analysis of the literature on non-medicated and drug-based methods of treatment of childhood obesity.
Verbatim abstract via PubMed 36689718 ↗